BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shalaby T, Grotzer MA. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies. Int J Mol Sci 2015;16:29103-19. [PMID: 26690130 DOI: 10.3390/ijms161226150] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sufianov A, Begliarzade S, Ilyasova T, Liang Y, Beylerli O. MicroRNAs as prognostic markers and therapeutic targets in gliomas. Noncoding RNA Res 2022;7:171-7. [PMID: 35846075 DOI: 10.1016/j.ncrna.2022.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhai Y, Zhou X, Wang X. Novel insights into the biomarkers and therapies for primary central nervous system lymphoma. Ther Adv Med Oncol 2022;14:175883592210937. [DOI: 10.1177/17588359221093745] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Nguyen HCB, Mady LJ, Panara K, Andrianus S, Cooper K, Chen IH, Chalian AA, Brody RM. Metastatic Meningioma of the Neck: A Case Report and Systematic Review. ORL J Otorhinolaryngol Relat Spec 2022;:1-9. [PMID: 35114675 DOI: 10.1159/000521076] [Reference Citation Analysis]
4 Choudhary R, Elabbas A, Vyas A, Osborne D, Chigurupati HD, Abbas LF, Kampa P, M H F, Sarwar H, Alfonso M. Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review. Cureus 2021;13:e20707. [PMID: 34966627 DOI: 10.7759/cureus.20707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Baichurina I, Valiullin V, James V, Rizvanov A, Mukhamedshina Y. The Study of Cerebrospinal Fluid microRNAs in Spinal Cord Injury and Neurodegenerative Diseases: Methodological Problems and Possible Solutions. Int J Mol Sci 2021;23:114. [PMID: 35008540 DOI: 10.3390/ijms23010114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Bevacqua E, Farshchi J, Niklison-Chirou MV, Tucci P. Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups. Cancers (Basel) 2021;13:6323. [PMID: 34944941 DOI: 10.3390/cancers13246323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sromek M, Rymkiewicz G, Paziewska A, Szafron LM, Kulecka M, Zajdel M, Kulinczak M, Dabrowska M, Balabas A, Bystydzienski Z, Chechlinska M, Siwicki JK. A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors. Biomolecules 2021;11:1395. [PMID: 34572608 DOI: 10.3390/biom11091395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Krause K, Wulf M, Sommer P, Barkovits K, Vorgerd M, Marcus K, Eggers B. CSF Diagnostics: A Potentially Valuable Tool in Neurodegenerative and Inflammatory Disorders Involving Motor Neurons: A Review. Diagnostics (Basel) 2021;11:1522. [PMID: 34573864 DOI: 10.3390/diagnostics11091522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang L, Chen S, Liu Y, Zhang H, Ren N, Ma R, He Z. The biological and diagnostic roles of MicroRNAs in meningiomas. Rev Neurosci 2020;31:771-8. [PMID: 32697762 DOI: 10.1515/revneuro-2020-0023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Pourhanifeh MH, Mahjoubin-Tehran M, Karimzadeh MR, Mirzaei HR, Razavi ZS, Sahebkar A, Hosseini N, Mirzaei H, Hamblin MR. Autophagy in cancers including brain tumors: role of MicroRNAs. Cell Commun Signal 2020;18:88. [PMID: 32517694 DOI: 10.1186/s12964-020-00587-w] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
11 Laneve P, Caffarelli E. The Non-coding Side of Medulloblastoma. Front Cell Dev Biol 2020;8:275. [PMID: 32528946 DOI: 10.3389/fcell.2020.00275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma. PLoS One 2020;15:e0229577. [PMID: 32101576 DOI: 10.1371/journal.pone.0229577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Kanchan RK, Siddiqui JA, Mahapatra S, Batra SK, Nasser MW. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy. Mol Cancer 2020;19:29. [PMID: 32059676 DOI: 10.1186/s12943-020-1140-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
14 Zajdel M, Rymkiewicz G, Sromek M, Cieslikowska M, Swoboda P, Kulinczak M, Goryca K, Bystydzienski Z, Blachnio K, Ostrowska B, Borysiuk A, Druzd-Sitek A, Walewski J, Chechlinska M, Siwicki JK. Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas. Cancers (Basel) 2019;11:E1647. [PMID: 31731456 DOI: 10.3390/cancers11111647] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
15 Kopkova A, Sana J, Machackova T, Vecera M, Radova L, Trachtova K, Vybihal V, Smrcka M, Kazda T, Slaby O, Fadrus P. Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors. Cancers (Basel) 2019;11:E1546. [PMID: 31614872 DOI: 10.3390/cancers11101546] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
16 Li Q, Li Y, Zhang D, Gao H, Gao X. Downregulation of microRNA‑451 improves cell migration, invasion and tube formation in hypoxia‑treated HUVECs by targeting MIF. Mol Med Rep 2019;20:1167-77. [PMID: 31173234 DOI: 10.3892/mmr.2019.10357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
17 Kopkova A, Sana J, Fadrus P, Slaby O. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors. Clin Chem Lab Med 2018;56:869-79. [PMID: 29451858 DOI: 10.1515/cclm-2017-0958] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
18 Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma. PLoS One 2019;14:e0210400. [PMID: 30615673 DOI: 10.1371/journal.pone.0210400] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
19 Dakubo GD. Brain Cancer Biomarkers in Proximal Fluids. Cancer Biomarkers in Body Fluids 2019. [DOI: 10.1007/978-3-030-24725-6_11] [Reference Citation Analysis]
20 Marioni-Henry K, Zaho D, Amengual-Batle P, Rzechorzek NM, Clinton M. Expression of microRNAs in cerebrospinal fluid of dogs with central nervous system disease. Acta Vet Scand 2018;60:80. [PMID: 30563542 DOI: 10.1186/s13028-018-0434-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kopkova A, Sana J, Fadrus P, Machackova T, Vecera M, Vybihal V, Juracek J, Vychytilova-Faltejskova P, Smrcka M, Slaby O. MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study. PLoS One 2018;13:e0208580. [PMID: 30532175 DOI: 10.1371/journal.pone.0208580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
22 Kotecki N, Lefranc F, Devriendt D, Awada A. Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives. Ther Adv Med Oncol 2018;10:1758835918780312. [PMID: 29977353 DOI: 10.1177/1758835918780312] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
23 Mochizuki AY, Frost IM, Mastrodimos MB, Plant AS, Wang AC, Moore TB, Prins RM, Weiss PS, Jonas SJ. Precision Medicine in Pediatric Neurooncology: A Review. ACS Chem Neurosci 2018;9:11-28. [PMID: 29199818 DOI: 10.1021/acschemneuro.7b00388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
24 Kit OI, Vodolazhsky DI, Rostorguev EE, Porksheyan DH, Panina SB. The Role of MicroRNA in Regulation of Signaling Pathways in Gliomas. Biochem Moscow Suppl Ser B 2018;12:1-21. [DOI: 10.1134/s1990750818010079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Galicia N, Dégano R, Díez P, González-gonzález M, Góngora R, Ibarrola N, Fuentes M. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma. Expert Review of Proteomics 2017;14:363-72. [DOI: 10.1080/14789450.2017.1307106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
26 McConnell HL, Kersch CN, Woltjer RL, Neuwelt EA. The Translational Significance of the Neurovascular Unit. J Biol Chem 2017;292:762-70. [PMID: 27920202 DOI: 10.1074/jbc.R116.760215] [Cited by in Crossref: 165] [Cited by in F6Publishing: 171] [Article Influence: 27.5] [Reference Citation Analysis]
27 Zhou X, Su S, Li S, Pang X, Chen C, Li J, Liu J. MicroRNA-146a down-regulation correlates with neuroprotection and targets pro-apoptotic genes in cerebral ischemic injury in vitro. Brain Res 2016;1648:136-43. [PMID: 27449900 DOI: 10.1016/j.brainres.2016.07.034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]